Combining Bone Collagen Matrix with hUC-MSCs for Application to Alveolar Process Cleft in a Rabbit Model

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Orthopedic Surgery

Background:

• Current bone defect treatments have limited efficacy due to poor osteoinduction.
• Human umbilical cord mesenchymal stem cells (hUC-MSCs) show potential for bone regeneration.
• The mechanism of combining hUC-MSCs with bone collagen matrix for alveolar cleft repair is not fully understood.

Purpose of the Study:

• To investigate the efficacy of combining a bone collagen matrix with hUC-MSCs for alveolar process cleft repair in a rabbit model.
• To elucidate the underlying mechanisms of enhanced bone regeneration.

Main Methods:

• A rabbit alveolar process cleft model was created.
• Bone defects were treated with either bone collagen matrix alone or combined with hUC-MSCs.
• Assessment of new bone formation and cellular activity using X-ray, micro-CT, histochemistry, and TUNEL assays at 3 and 6 months.

Main Results:

• The hUC-MSC combination group showed significantly higher bone formation rates compared to controls at both 3 and 6 months.
• Apoptosis rates in the hUC-MSC group were elevated at 3 months but reduced at 6 months post-surgery.

Conclusions:

• Combining bone collagen matrix with hUC-MSCs effectively promotes new bone regeneration in alveolar process cleft defects.
• The mechanism involves enhanced osteoblast formation, chondrocyte growth, type I collagen production, and BMP-2 generation.